Under evaluation with potential for adoption
Peezy Midstream: reliable urine collection + cost savings
Peezy Midstream is a novel MedTech Device that delivers right-first-time urine analysis, diagnosis and treatment.
About
Peezy is proven to reduce urine specimen mixed growth from a national average 18% to just 1.5%. It is on the NHS Supply Chain Catalogue and the Drug Tariff, so can be prescribed for the very young, elderly and antenatal use.
- Evidence points to tangible benefits arising from more reliable collection:
- significant improvements in urine analysis accuracy, leading to right-first-time patient care
- fewer retests leading to financial savings on lab analysis, repeat appointments, staff and resource time
- reduced retests in the lab freeing up more time for first-time tests
- Peezy collects midstream urine into the lab-friendly 10ml Primary Tube removing need for decanting by either frontline or laboratory staff
- improved targeted prescribing over broad spectrum antibiotics, used when results are equivocal
Addtionally, Peezy Midstream removes spills and splashing:
- improves and assists infection control
- dry hands for patient are more hygenic and dignified
- dry bottle relieves frontline staff from handling soiled containers